Similar Papers

Paper Title
Journal
Date
Author
DOP84 Risankizumab maintenance therapy results in sustained improvements in endoscopic outcomes in patients with moderate to severe Crohn’s Disease: Post-hoc analysis from the phase 3 study FORTIFY
P M Irving ... R Panaccione
Journal of Crohn's and Colitis | VOL. 16
P M Irving, et. al.P M Irving ... R Panaccione
21 Jan 2022
OP25 Patients with moderate to severe Crohn’s Disease with and without prior biologic failure demonstrate improved endoscopic outcomes with risankizumab: Results from phase 3 induction and maintenance trials
M Ferrante ... A Song
Journal of Crohn's and Colitis | VOL. 16
M Ferrante, et. al.M Ferrante ... A Song
21 Jan 2022
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease.
Robert Battat ... Waqqas Afif
Clinical Gastroenterology and Hepatology | VOL. 15
Robert Battat, et. al.Robert Battat ... Waqqas Afif
29 Mar 2017
P307 Modelling of the relationship between ustekinumab exposure, faecal calprotectin and endoscopic outcomes in patients with Crohn’s disease
Z Wang ... P Declerck
Journal of Crohn's and Colitis | VOL. 15
Z Wang, et. al.Z Wang ... P Declerck
27 May 2021
View more papers

More From: Gut

Paper Title
Journal
Date
Author
Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial.
Alexandra Wright-Hughes ... Alexander C Ford
Gut | VOL. -
Alexandra Wright-Hughes, et. al.Alexandra Wright-Hughes ... Alexander C Ford
25 Jan 2025
Metabolic dysfunction-associated steatotic liver disease in children
Nidhi P Goyal ... Jeffrey B Schwimmer
Gut | VOL. -
Nidhi P Goyal, et. al.Nidhi P Goyal ... Jeffrey B Schwimmer
23 Jan 2025
An unusual cause of oesophageal stricture
Ya-Qi Gao ... Dan-Feng Sun
Gut | VOL. -
Ya-Qi Gao, et. al.Ya-Qi Gao ... Dan-Feng Sun
22 Jan 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
Panagiota Maravelia ... Anna Pasetto
Gut | VOL. -
Panagiota Maravelia, et. al.Panagiota Maravelia ... Anna Pasetto
18 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.